Discriminating nodular pulmonary alveolar proteinosis from lung adenocarcinoma with radiomic model and multimodal model
Therapeutic Advances in Respiratory Disease · 2026-03 · 20
DOI: 10.1177/17534666261436223 ↗Kurz gefasst
Fachartikel in der Zeitschrift Therapeutic Advances in Respiratory Disease, online erschienen am 29.03.2026. Verfasst von Qing Chang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary and Critical Care Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, P.R. China. Hauptthemen laut MEDLINE: Pulmonary Alveolar Proteinosis, Lung Neoplasms, Adenocarcinoma of Lung, Tomography, X-Ray Computed. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: school of medicine, shanghai jiao tong university, shanghai jiao tong university, Shanghai Municipal Medical Outstanding Young Medical Talent Training Program.
Abstract (Originalsprache)
Background
Pulmonary alveolar proteinosis (PAP) typically manifests as diffuse lung disease, while nodular PAP presenting as pulmonary nodules is extremely rare and often radiologically indistinguishable from early-stage lung adenocarcinoma (LUAD).
Objectives
This study aims to establish an accurate diagnostic algorithm to prevent unnecessary invasive procedures in patients with nodular PAP.
Design
This study was a retrospective, single-center study.
Methods
This study enrolled 16 pathologically confirmed nodular PAP patients and 52 early-stage LUAD patients, systematically comparing their clinical characteristics and biochemical markers. A radiomics model was developed based on CT imaging features, followed by a multimodal model incorporating significant clinical and biochemical discriminators.
Results
The nodular PAP cohort demonstrated a 3:5 male-to-female ratio, equivalent distribution of solitary versus multiple nodules, and nodule diameters spanning 3–28 mm. Nodular PAP patients were significantly younger (mean 51.4 vs 67.0 years, p < 0.001), had higher body mass index (BMI, 25.8 ± 2.5 vs 23.7 ± 2.8 kg/m², p < 0.01), and lower lactate dehydrogenase levels (LDH, 188.44 ± 26.71 vs 214.79 ± 56.84 U/L, p = 0.01) compared to LUAD patients. The radiomic model achieved an AUC (area under the curve) of 0.91, while the multimodal model combining clinical and biochemical features showed similar performance (AUC = 0.97).
Conclusion
This study provides the characterization of nodular PAP and establishes radiomic and multimodal diagnostic models with similar accuracy, which are reliable tools to make a differential diagnosis between nodular PAP and LUAD and to prevent unnecessary surgery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pulmonary and Critical Care Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, P.R. China.
- School of Biomedical Engineering, Shanghai Jiao Tong University, Minhang, Shanghai, P.R. China.
- School of Biomedical Engineering, Shanghai Jiao Tong University, No. 800, Dongchuan Road, Minhang, Shanghai 200240, P.R. China.
- Department of Pulmonary Medicine and Critical Care, Shanghai Chest Hospital, School of Medicine, Shanghai Jiao Tong University, No. 241, West Huaihai Road, Shanghai 200030, P.R. China.
ORCID-Profile: Qing Chang, Feng Li
Förderung
- school of medicine, shanghai jiao tong university
- shanghai jiao tong university
- Shanghai Municipal Medical Outstanding Young Medical Talent Training Program
- Shanghai Municipal Health Commission
Zitieren
APA
Chang, Q., Zhang, H., Xu, N., Mao, R., Li, M., Zhang, H., Chen, Y., Sun, J., & Li, F. (2026). Discriminating nodular pulmonary alveolar proteinosis from lung adenocarcinoma with radiomic model and multimodal model. Therapeutic Advances in Respiratory Disease, 20. https://doi.org/10.1177/17534666261436223
Vancouver
Chang Q, Zhang H, Xu N, Mao R, Li M, Zhang H, et al. Discriminating nodular pulmonary alveolar proteinosis from lung adenocarcinoma with radiomic model and multimodal model. Therapeutic Advances in Respiratory Disease. 2026;20. doi:10.1177/17534666261436223
BibTeX
@article{Chang2026,
author = {Chang, Qing and Zhang, Huaizhe and Xu, Ning and Mao, Ruolin and Li, Mengnan and Zhang, Hai and Chen, Yuqing and Sun, Jianqi and Li, Feng},
title = {Discriminating nodular pulmonary alveolar proteinosis from lung adenocarcinoma with radiomic model and multimodal model},
journal = {Therapeutic Advances in Respiratory Disease},
year = {2026},
volume = {20},
doi = {10.1177/17534666261436223}
}
EUVIMED